Income Tax Expense (Benefit) in USD of Autolus Therapeutics plc from 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Autolus Therapeutics plc quarterly/annual Income Tax Expense (Benefit) history and change rate from 2016 to Q3 2025.
  • Autolus Therapeutics plc Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $532K, a 2318% increase year-over-year.
  • Autolus Therapeutics plc Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $4.62M, a 11161% increase year-over-year.
  • Autolus Therapeutics plc annual Income Tax Expense (Benefit) for 2024 was $1.53M.
  • Autolus Therapeutics plc annual Income Tax Expense (Benefit) for 2023 was -$19K, a 107% decline from 2022.
  • Autolus Therapeutics plc annual Income Tax Expense (Benefit) for 2022 was $272K, a 369% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Autolus Therapeutics plc Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $4.62M $532K +$510K +2318% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $4.11M $397K +$346K +678% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 $3.76M $2.23M +$2.23M 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $1.53M $1.46M +$1.49M 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025
Q3 2024 $41K $22K +$43K 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 -$2K $51K +$11K +27.5% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 -$13K -$8K +$6K +42.9% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 -$19K -$24K -$383K -107% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025
Q3 2023 $364K -$21K -$16K -320% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 $380K $40K +$96K 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 $284K -$14K +$12K +46.2% 01 Jan 2023 31 Mar 2023 10-Q 17 May 2024
Q4 2022 $272K $359K 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024
Q3 2022 -$5K 01 Jul 2022 30 Sep 2022 10-K 21 Mar 2024
Q2 2022 -$56K 01 Apr 2022 30 Jun 2022 10-K 21 Mar 2024
Q1 2022 -$26K +$5.7M +99.5% 01 Jan 2022 31 Mar 2022 10-K 21 Mar 2024
Q1 2021 -$26.2M -$5.72M -$2.03M -54.9% 01 Jan 2021 31 Mar 2021 6-K 06 May 2021
Q4 2020 -$24.2M -$5.58M -$1.72M -44.4% 01 Oct 2020 31 Dec 2020 20-F 07 Mar 2023
Q3 2020 -$22.4M -$7.87M -$3.27M -71.1% 01 Jul 2020 30 Sep 2020 6-K 05 Nov 2020
Q2 2020 -$19.2M -$7.02M -$3.75M -114% 01 Apr 2020 30 Jun 2020 6-K 06 Aug 2020
Q1 2020 -$15.4M -$3.7M -$275K -8.04% 01 Jan 2020 31 Mar 2020 6-K 06 May 2021
Q4 2019 -$15.2M -$3.87M -$1.26M -48.4% 01 Oct 2019 31 Dec 2019 20-F 10 Mar 2022
Q3 2019 -$13.9M -$4.6M -$2.4M -109% 01 Jul 2019 30 Sep 2019 6-K 05 Nov 2020
Q2 2019 -$11.5M -$3.27M -$1.06M -47.7% 01 Apr 2019 30 Jun 2019 6-K 06 Aug 2020
Q1 2019 -$10.4M -$3.42M 01 Jan 2019 31 Mar 2019 6-K 07 May 2020
Q4 2018 -$2.61M -$1.21M -86.5% 01 Oct 2018 31 Dec 2018 20-F 04 Mar 2021
Q3 2018 -$2.2M 01 Jul 2018 30 Sep 2018 6-K 07 Nov 2019
Q2 2018 -$2.22M 01 Apr 2018 30 Jun 2018 6-K 08 Aug 2019
Q4 2017 -$1.4M 01 Oct 2017 31 Dec 2017 20-F 25 Feb 2019

Autolus Therapeutics plc Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.53M +$1.55M 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025
2023 -$19K -$291K -107% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025
2022 $272K +$214K +369% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
2021 $58K +$24.2M 01 Jan 2021 31 Dec 2021 10-K 21 Mar 2024
2020 -$24.2M -$9M -59.4% 01 Jan 2020 31 Dec 2020 20-F 07 Mar 2023
2019 -$15.2M -$7.88M -108% 01 Jan 2019 31 Dec 2019 20-F 10 Mar 2022
2018 -$7.28M -$3.63M -99.3% 01 Oct 2017 30 Sep 2018 20-F 03 Mar 2020
2017 -$3.65M -$1.88M -106% 01 Oct 2016 30 Sep 2017 20-F 03 Mar 2020
2016 -$1.78M 01 Oct 2015 30 Sep 2016 20-F 25 Feb 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.